The US Food and Drug Administration has approved a new system for nerve repair based on light-activated polymers rather than surgical stitches. The flexible polymer system was developed by the medical technology company Tissium, which was founded over a decade ago to commercialize research from the laboratories of Jeffrey M. Karp and Bob Langer at the Massachusetts Institute of Technology.

Approval is the first for firm Tissium, which was founded over a decade ago by Laura Howes.